ATE189207T1 - Bistriazene als chemotherapeutische wirkstoffe - Google Patents
Bistriazene als chemotherapeutische wirkstoffeInfo
- Publication number
- ATE189207T1 ATE189207T1 AT92923053T AT92923053T ATE189207T1 AT E189207 T1 ATE189207 T1 AT E189207T1 AT 92923053 T AT92923053 T AT 92923053T AT 92923053 T AT92923053 T AT 92923053T AT E189207 T1 ATE189207 T1 AT E189207T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- bistriazene
- cancer
- bistriazenes
- chemotherapeutic agents
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 229940127089 cytotoxic agent Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 230000001093 anti-cancer Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003431 cross linking reagent Substances 0.000 abstract 1
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/22—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond containing chains of three or more nitrogen atoms with one or more nitrogen-to-nitrogen double bonds
- C07C245/24—Chains of only three nitrogen atoms, e.g. diazoamines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78600191A | 1991-10-31 | 1991-10-31 | |
| PCT/US1992/009127 WO1993009089A1 (en) | 1991-10-31 | 1992-10-30 | Bistriazenes as chemotherapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE189207T1 true ATE189207T1 (de) | 2000-02-15 |
Family
ID=25137306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92923053T ATE189207T1 (de) | 1991-10-31 | 1992-10-30 | Bistriazene als chemotherapeutische wirkstoffe |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0626943B1 (de) |
| JP (1) | JP3193379B2 (de) |
| AT (1) | ATE189207T1 (de) |
| AU (1) | AU665036B2 (de) |
| CA (1) | CA2122346C (de) |
| DE (1) | DE69230622T2 (de) |
| DK (1) | DK0626943T3 (de) |
| ES (1) | ES2141114T3 (de) |
| GR (1) | GR3032953T3 (de) |
| WO (1) | WO1993009089A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE513149C2 (sv) * | 1997-12-05 | 2000-07-17 | Katarina Edwards | Läkemedelsdistributionssystem med tvåstegsmålsökning, till specifika celler eller vävnad och till dess cellkärna |
| WO2020121304A1 (en) * | 2018-12-10 | 2020-06-18 | Ariel Scientific Innovations Ltd. | Therapeutic conjugates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE514033A (fr) * | 1951-09-21 | 1954-05-14 | Cfmc | Procede d'obtention de colorants azoiques insolubles sur fibres. |
| US3947247A (en) * | 1973-10-31 | 1976-03-30 | Central Michigan University Board Of Trustees | Stabilizer composition for dyestuffs |
| DE3426644A1 (de) * | 1984-07-19 | 1986-02-06 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg | N,n-bis((1-aryl-3-methyltriazen-3-yl) methyl)ether |
| DE69131481T2 (de) * | 1990-05-24 | 1999-11-25 | The United States Of America, Represented By The Secretary | Bistriazene als chemotherapeutische mittel |
-
1992
- 1992-10-30 WO PCT/US1992/009127 patent/WO1993009089A1/en not_active Ceased
- 1992-10-30 CA CA002122346A patent/CA2122346C/en not_active Expired - Fee Related
- 1992-10-30 DK DK92923053T patent/DK0626943T3/da active
- 1992-10-30 DE DE69230622T patent/DE69230622T2/de not_active Expired - Fee Related
- 1992-10-30 ES ES92923053T patent/ES2141114T3/es not_active Expired - Lifetime
- 1992-10-30 JP JP50851093A patent/JP3193379B2/ja not_active Expired - Fee Related
- 1992-10-30 AT AT92923053T patent/ATE189207T1/de not_active IP Right Cessation
- 1992-10-30 EP EP92923053A patent/EP0626943B1/de not_active Expired - Lifetime
- 1992-10-30 AU AU29103/92A patent/AU665036B2/en not_active Ceased
-
2000
- 2000-03-10 GR GR20000400649T patent/GR3032953T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2122346C (en) | 2005-09-27 |
| GR3032953T3 (en) | 2000-07-31 |
| JPH07507042A (ja) | 1995-08-03 |
| EP0626943B1 (de) | 2000-01-26 |
| CA2122346A1 (en) | 1993-05-13 |
| JP3193379B2 (ja) | 2001-07-30 |
| AU665036B2 (en) | 1995-12-14 |
| ES2141114T3 (es) | 2000-03-16 |
| EP0626943A1 (de) | 1994-12-07 |
| DE69230622D1 (de) | 2000-03-02 |
| WO1993009089A1 (en) | 1993-05-13 |
| DE69230622T2 (de) | 2000-07-20 |
| AU2910392A (en) | 1993-06-07 |
| DK0626943T3 (da) | 2000-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9100016A (pt) | Composto,isotopo radioativo do mesmo,composicao farmaceutica,metodo de tratamento ou prevencao de estados de mamiferos | |
| FI980341A0 (fi) | 2-oksi-indolijohdannaisia | |
| ATE7697T1 (de) | Substituierte pyrazinyl-1,2,4-oxadiazol-5-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
| ATE182468T1 (de) | Bistriazene als chemotherapeutische mittel | |
| YU13396A (sh) | N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima | |
| ES2133324T3 (es) | Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y metodos de uso. | |
| DE68902301D1 (de) | Diarylverbindungen als antiatherosklerotische mittel. | |
| DE59203006D1 (de) | Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel. | |
| KR960703863A (ko) | 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer) | |
| ATE41772T1 (de) | Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
| GR75683B (de) | ||
| ATE189207T1 (de) | Bistriazene als chemotherapeutische wirkstoffe | |
| BR9106272A (pt) | Composicoes farmaceuticas contendo ipriflavona,processo para sua preparacao e uso terapeutico relativo | |
| ATE220393T1 (de) | Eine heteroethynylen-brücke enthaltende bi- aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen | |
| DE3370157D1 (en) | Derivatives of tricyclophosphazenes, process for their preparation and their use as medicines | |
| NZ233704A (en) | Dehydrocholecalciferol derivatives, pharmaceutical compositions thereof | |
| ITMI920084A1 (it) | Alchil derivati del trazodone | |
| DE58903821D1 (de) | Verwendung von addukten von 1,2-butylenoxid an aminen als schmierstoffe und schmierstoffe, diese addukte enthaltend. | |
| DE69311123D1 (de) | Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe | |
| SE8200649L (sv) | Polycykliska foreningar innehallande en dubbelbindning i d-ringen, sett for deras framstellning och farmaceutiska beredningar innehallande dem | |
| ATE118763T1 (de) | Phenolisches amin als antimelanoma- und depigmentierungsmittel. | |
| KR890017363A (ko) | 스트로빌루린 유도체, 이들의 제법 및 용도 | |
| NO903291D0 (no) | Renin-hemmende aminooligohydroksy-derivater. | |
| SE7708452L (sv) | Komposition innehallande en antrakinonforening | |
| ATE41774T1 (de) | (+)-cyanidan-3-ol derivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |